Literature DB >> 27179963

DDR1 enhances invasion and metastasis of gastric cancer via epithelial-mesenchymal transition.

Ruixia Xie1, Xiaoying Wang1, Guoqing Qi1, Zhiping Wu1, Rong Wei1, Peirong Li1, Dekui Zhang2.   

Abstract

In this study, we investigated the effects of DDR1 on the invasion and metastasis in gastric cancer (GC) via epithelial-mesenchymal transition (EMT). Immunohistochemistry analysis was used to detect DDR1, E-cadherin, and Vimentin expression in GC tissues as well as DDR1 expression in GC cell lines and normal gastric epithelial cells. The relationship between DDR1 expression and EMT in GC cell lines was explored by down and upregulating DDR1 and examining corresponding changes in the expression of EMT-related proteins and in biological characteristics. Furthermore, a nude mice model with a transplantation tumor generating from stably transfected GC cells with DDR1 overexpression was established and performed to further reveal the effects of DDR1 expression on cellular morphology and growth of GC. Our results showed that DDR1 was highly expressed in GC tissues and cell lines compared with adjacent tissues and normal cell line, and its expression was significantly higher in GC having poor differentiation (p < 0.01), advanced depth of wall invasion (p = 0.020), lymph node metastasis (p = 0.0001), liver metastasis (p < 0.01), and high TNM stage (p < 0.01). Western blot analyses revealed that DDR1 overexpression resulted in a significant decrease in the expression of E-cadherin (p < 0.01) and an increase in the expression of Vimentin and Snail (p < 0.01), while knockdown of DDR1 led to opposite outcomes. We further demonstrated that DDR1 overexpression promoted GC cell proliferation (p < 0.05), migration (p < 0.01), and invasion (p < 0.01), and accelerated the growth (p < 0.05) as well as the microvessel formation (p < 0.01) of transplantation tumor in nude mice. Our study establishes that DDR1 enhances invasion and metastasis of gastric cancer via EMT.

Entities:  

Keywords:  DDR1; EMT; Gastric cancer; Invasion; Transplantation tumor

Mesh:

Substances:

Year:  2016        PMID: 27179963     DOI: 10.1007/s13277-016-5070-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  57 in total

Review 1.  Tumor metastasis: mechanistic insights and clinical challenges.

Authors:  Patricia S Steeg
Journal:  Nat Med       Date:  2006-08       Impact factor: 53.440

2.  ras p21 expression in the progression of breast cancer.

Authors:  F B Fromowitz; M V Viola; S Chao; S Oravez; Y Mishriki; G Finkel; R Grimson; J Lundy
Journal:  Hum Pathol       Date:  1987-12       Impact factor: 3.466

3.  Fas signaling promotes motility and metastasis through epithelial-mesenchymal transition in gastrointestinal cancer.

Authors:  H X Zheng; Y D Cai; Y D Wang; X B Cui; T T Xie; W J Li; L Peng; Y Zhang; Z Q Wang; J Wang; B Jiang
Journal:  Oncogene       Date:  2012-04-16       Impact factor: 9.867

4.  Runx3 protects gastric epithelial cells against epithelial-mesenchymal transition-induced cellular plasticity and tumorigenicity.

Authors:  Dominic Chih-Cheng Voon; Huajing Wang; Jason Kin Wai Koo; Tu Anh Pham Nguyen; Yit Teng Hor; Yeh-Shiu Chu; Kosei Ito; Hiroshi Fukamachi; Shing Leng Chan; Jean Paul Thiery; Yoshiaki Ito
Journal:  Stem Cells       Date:  2012-10       Impact factor: 6.277

5.  Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion.

Authors:  Qingli Shen; Vito R Cicinnati; Xiaoyong Zhang; Speranta Iacob; Frank Weber; Georgios C Sotiropoulos; Arnold Radtke; Mengji Lu; Andreas Paul; Guido Gerken; Susanne Beckebaum
Journal:  Mol Cancer       Date:  2010-08-27       Impact factor: 27.401

6.  Prognostic value of microvessel density in prostate cancer: a tissue microarray study.

Authors:  Andreas Erbersdobler; Hendrik Isbarn; Kira Dix; Isabel Steiner; Thorsten Schlomm; Martina Mirlacher; Guido Sauter; Alexander Haese
Journal:  World J Urol       Date:  2009-08-28       Impact factor: 4.226

7.  Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer.

Authors:  Keiji Shimada; Mitsutoshi Nakamura; Eiwa Ishida; Tomonori Higuchi; Hiroshi Yamamoto; Kazutake Tsujikawa; Noboru Konishi
Journal:  Cancer Sci       Date:  2007-10-29       Impact factor: 6.716

8.  Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells.

Authors:  Chie Kudo-Saito; Hiromi Shirako; Tadashi Takeuchi; Yutaka Kawakami
Journal:  Cancer Cell       Date:  2009-03-03       Impact factor: 31.743

9.  DDR1 triggers epithelial cell differentiation by promoting cell adhesion through stabilization of E-cadherin.

Authors:  Yi-Chun Yeh; Chia-Ching Wu; Yang-Kao Wang; Ming-Jer Tang
Journal:  Mol Biol Cell       Date:  2011-02-02       Impact factor: 4.138

10.  Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma.

Authors:  C E Ford; S K Lau; C Q Zhu; T Andersson; M S Tsao; W F Vogel
Journal:  Br J Cancer       Date:  2007-02-13       Impact factor: 7.640

View more
  16 in total

Review 1.  Complex roles of discoidin domain receptor tyrosine kinases in cancer.

Authors:  V Mehta; H Chander; A Munshi
Journal:  Clin Transl Oncol       Date:  2021-02-25       Impact factor: 3.405

2.  E2F1 silencing inhibits migration and invasion of osteosarcoma cells via regulating DDR1 expression.

Authors:  Zhaofeng Wang; Xianjie Sun; Yi Bao; Juanfen Mo; Hengchao Du; Jichao Hu; Xingen Zhang
Journal:  Int J Oncol       Date:  2017-10-16       Impact factor: 5.650

3.  Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression.

Authors:  Yuao Deng; Fang Zhao; Liu Hui; Xiuyun Li; Danyu Zhang; Wang Lin; Zhiqiang Chen; Yingxia Ning
Journal:  J Ovarian Res       Date:  2017-07-25       Impact factor: 4.234

4.  High Expression of Peroxiredoxin 1 Is Associated with Epithelial-Mesenchymal Transition Marker and Poor Prognosis in Gastric Cancer.

Authors:  Wei Yu; Jing Wu; Zhong-Liang Ning; Qiao-Yu Liu; Rui-Liang Quan
Journal:  Med Sci Monit       Date:  2018-04-15

5.  TGF-β1-SOX9 axis-inducible COL10A1 promotes invasion and metastasis in gastric cancer via epithelial-to-mesenchymal transition.

Authors:  Tingting Li; Haipeng Huang; Guangyao Shi; Liying Zhao; Tuanjie Li; Ze Zhang; Ruoyan Liu; Yanfeng Hu; Hao Liu; Jiang Yu; Guoxin Li
Journal:  Cell Death Dis       Date:  2018-08-28       Impact factor: 8.469

6.  The role and molecular mechanism of Trop2 induced epithelial-mesenchymal transition through mediated β-catenin in gastric cancer.

Authors:  Wei Zhao; Lizhou Jia; Xingwang Kuai; Qi Tang; Xiaochen Huang; Tingting Yang; Zhenning Qiu; Jin Zhu; Jianfei Huang; Wenbin Huang; Zhenqing Feng
Journal:  Cancer Med       Date:  2019-01-11       Impact factor: 4.452

Review 7.  Transmembrane Peptides as Inhibitors of Protein-Protein Interactions: An Efficient Strategy to Target Cancer Cells?

Authors:  Camille Albrecht; Aline Appert-Collin; Dominique Bagnard; Sébastien Blaise; Béatrice Romier-Crouzet; Roman G Efremov; Hervé Sartelet; Laurent Duca; Pascal Maurice; Amar Bennasroune
Journal:  Front Oncol       Date:  2020-04-15       Impact factor: 6.244

8.  Inhibition of discoidin domain receptors by imatinib prevented pancreatic fibrosis demonstrated in experimental chronic pancreatitis model.

Authors:  Sapana Bansod; Mohd Aslam Saifi; Chandraiah Godugu
Journal:  Sci Rep       Date:  2021-06-18       Impact factor: 4.379

9.  Collagen Induces a More Proliferative, Migratory and Chemoresistant Phenotype in Head and Neck Cancer via DDR1.

Authors:  Sook Ling Lai; May Leng Tan; Robert J Hollows; Max Robinson; Maha Ibrahim; Sandra Margielewska; E Kenneth Parkinson; Anand Ramanathan; Rosnah Binti Zain; Hisham Mehanna; Rachel J Spruce; Wenbin Wei; Ivy Chung; Paul G Murray; Lee Fah Yap; Ian C Paterson
Journal:  Cancers (Basel)       Date:  2019-11-09       Impact factor: 6.639

10.  Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib.

Authors:  Raquel Carvalho Montenegro; Alison Howarth; Alessandro Ceroni; Vita Fedele; Batoul Farran; Felipe Pantoja Mesquita; Martin Frejno; Benedict-Tilman Berger; Stephanie Heinzlmeir; Heba Z Sailem; Roberta Tesch; Daniel Ebner; Stefan Knapp; Rommel Burbano; Bernhard Kuster; Susanne Müller
Journal:  Oncotarget       Date:  2020-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.